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Acute lung injury (ALI) is a life threatening condition associated with hypoxemia, diffuse
alveolar damage, inﬂammation, and loss of lung function. Lipopolysaccharide (LPS; endo-
toxin) from the outer membrane of Gram-negative bacteria is a major virulence factor
involved in the development of ALI. The depletion of glutathione (GSH), an essential intra-
and extra-cellular protective antioxidant, by LPS is an important event that contributes to
the elevation in reactive oxygen species. Whether restoring GSH homeostasis can effec-
tively ameliorate mitochondrial dysfunction and cellular apoptosis in ALI is unknown and
therefore, was the focus of this study. In peripheral lung tissue of LPS-treated mice, hydro-
gen peroxide and protein nitration levels were signiﬁcantly increased. Pre-treatment with
GSH-ethyl ester (GSH-EE) prevented this increase in oxidative stress. LPS also increased
the lactate/pyruvate ratio, attenuated SOD2 protein levels, and decreased ATP levels in the
mouse lung indicative of mitochondrial dysfunction. Again, GSH-EE treatment preserved
the mitochondrial function. Finally, our studies showed that LPS induced an increase in the
mitochondrial translocation of Bax, caspase 3 activation, and nuclear DNA fragmentation
and these parameters were all prevented with GSH-EE. Thus, this study suggests that
GSH-EE supplementation may reduce the mitochondrial dysfunction associated with ALI.
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INTRODUCTION
Acute lung injury (ALI) is an acute inﬂammatory disorder associ-
ated with both high morbidity and mortality in afﬂicted patients
even under intensive care. ALI is characterized by non-cardiogenic
dyspnea, hypoxemia, pulmonary neutrophil sequestration, and
low lung compliance (Martinez et al., 2009). ALI can occur in
response to direct insults, such as viral or bacterial infections of
the lung, hyperoxia, and acid aspiration, or indirect insults like
sepsis, multiple transfusions, and pancreatitis. Lipopolysaccha-
ride (LPS) from the outer cell wall of Gram-negative bacteria that
cause sepsis is the most common indirect pulmonary insult lead-
ing to ALI (Erickson et al., 2009). LPS provokes damage to the
alveolar-capillary membrane and the adhesion, activation, and
sequestration of polymorphonuclear neutrophils (PMN), which
result in the deterioration of gas exchange (Nagase et al., 2003).
Although several therapies, such as corticosteroids, prostacyclins,
exogenous surfactants, ketoconazole, and nitric oxide, have shown
promising outcomes, the estimated mortality rate in ALI is 38.5%
(Rubenfeld et al., 2005). Therefore, there is a further need to study
the pathophysiology of ALI and identify therapeutic targets to
improve patient outcome.
Glutathione (GSH), a tripeptide thiol, is the most potent
antioxidant found in the cell and plays a protective role against
reactive oxygen and nitrogen species (ROS and RNS) mediated
injury and lung inﬂammation (Li et al., 1994; van Klaveren et al.,
1997). This antioxidant is also involved in the regulation of apop-
tosis, cell proliferation, and gene transcription (Rahman andMac-
Nee, 2000b; Luppi et al., 2005). GSH alsomodiﬁes protein sulfdryl
groups by a number of reactions: reduction of protein sulfenic
acids, formation of protein mixed disulﬁdes, and their subsequent
reduction. The conjugation of GSHwith electrophilic compounds
mediated by glutathione S-transferases (GSTs) and the subsequent
excretion of these conjugates from the cell also serve to protect
against toxins, such as LPS. GSH and GSH-associated enzymes
present in the lower respiratory tract act as the ﬁrst line of defense
against external agents (DeLeve and Kaplowitz, 1990; Pacht et al.,
1991). Alterations in alveolar and lungGSHmetabolism have been
shown to be a central feature of many inﬂammatory lung diseases,
such as acute respiratory distress syndrome (ARDS), cystic ﬁbro-
sis, and asthma (Rahman and MacNee, 2000a). GSH levels are
signiﬁcantly reduced in bronchoalveolar lavage ﬂuid (BALF) from
patients with ALI (Pacht et al., 1991). Further, it has been reported
that disruptions in thiol status are associated with ALI (Quinlan
et al., 1994, 1997).
Apoptosis, or programmed cell death, is an essential phys-
iological phenomenon responsible for the selective elimination
of cells. However, the dysregulation of apoptotic signaling path-
ways is thought to play an important role in the development
of ALI (Z’Graggen et al., 2010). Several studies have shown com-
pelling evidence that increased epithelial/endothelial cell apoptosis
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signiﬁcantly contributes to the damage to the pulmonary alveolar-
capillary interface in ALI (Kitamura et al., 2001). The inhibition of
apoptosis increases survival in animal models of LPS-induced ALI
(Kawasaki et al., 2000; Ma et al., 2010). Previously, we have shown
that key mechanisms of zinc-mediated apoptotic induction in
pulmonary endothelial cells include the disruption of cellular glu-
tathione homeostasis and decreased mitochondrial ATP synthesis
(Wiseman et al., 2010). We found that the acute increases in both
oxidative and nitrosative stress (similar to that occurring in ALI)
in endothelial cells led to a signiﬁcant increase in cellular apopto-
sis, which was attenuated by pre-treatment with GSH-ethyl ester
(GSH-EE) (Wisemanet al.,2010). Therefore, the focus of this study
was to determinewhetherGSH supplementation can prevent LPS-
mediated ROS/RNS generation, mitochondrial dysfunction, and
cellular apoptosis in mouse model of LPS-induced ALI.
MATERIALS AND METHODS
ANIMAL TREATMENTS
Adult male C57BL/6NHsd mice (7–8weeks; Harlan, Indianapo-
lis, IN, USA) were used in all experiments and housed in a
temperature-controlled animal facilitywith 12-h light–dark cycles.
All animal care and experimental procedures were approved by
the Committee on Animal Use in Research and Education of the
Georgia Health Sciences University (Augusta, GA, USA). Mice
were divided into four experimental groups (n = 6/group); Vehi-
cle, LPS, GSH-EE+ LPS, and GSH-EE alone, respectively. Mice
were injected intraperitoneally either with saline (vehicle) or LPS
(6.75× 104 EU/g body wt), as previously published (Chatterjee
et al., 2008). The group of mice receiving both GSH-EE and LPS
were injected with two separate doses of 2mmol GSH-EE/kg body
wt (Sigma, St. Louis, MO, USA; Singhal and Jain, 2000). Dose
1 was given 2 h prior to LPS and dose 2 was given along with
LPS injection. The pH of the GSH-EE solution was adjusted to
6.8 by the addition of 2M NaOH immediately before injection.
Mice belonging to GSH-EE alone group received similar GSH-EE
doses. LPS only and GSH-EE+ LPS groups of mice were euth-
anized 12 h after LPS injection, and the lungs were ﬂushed with
ice-cold EDTA-PBS, excised, snap-frozen in liquid nitrogen, and
stored at −80˚C until used.
LUNG TISSUE HOMOGENATES
Lung protein extracts were prepared by homogenizing mouse
lung tissues in Triton lysis buffer (50mM Tris–HCL, pH 7.6,
0.5% Triton X-100, 20% glycerol) containing a protease inhibitor
cocktail (Sigma). Extracts were then clariﬁed by centrifugation
(14,000 rpm for 10min at 4˚C). Supernatant fractions were then
assayed for protein concentration using the Bradford reagent (Bio-
Rad, Richmond, CA, USA). Mitochondria were isolated from all
four groups of mice lungs using the Mitochondria Isolation Kit
(Thermo Fisher Scientiﬁc Inc., Rockford, IL, USA) and analyzed
by western blot to detect the Bax protein levels.
MEASUREMENT OF GSH LEVELS
Tissue samples were homogenized in 5% sulfosalicylic acid (SSA)
and centrifuged at 12,000× g for 15min. Hundred microliters of
supernatant was brought to neutral pH by using triethanolamine
and split into two tubes, one for the total GSH/GSSG and another
to measure the GSSG levels alone (Grifﬁth, 1980). Twomicroliters
of 2-vinylpyridine (2-VP)was added to the sample tubemeasuring
GSSG levels alone and placed on a rocker for an hour. 2-VPmasks
GSH and prevents its reaction with 5,5′-dithio-bis(2-nitrobenzoic
acid; DTNB), thereby measuring only oxidized GSSG levels. Five
microliters of 50U/mL glutathione reductase was added to both
the tubes to convert GSSG to GSH. The reaction was then initi-
ated in both tubes by adding, 50μL of 6mMDTNB and 350μL of
0.3mM NADPH. All solutions were made with 125mM NaHPO4
buffer (pH 7.5) containing 6.3mM EDTA. The increase in the
absorbance was measured at 412 nm. Reduced GSH levels were
extrapolated from the GSH/GSSG ratio and the oxidized GSSG
levels and then normalized to tissue wet weight.
IN SITU DETECTION OF H2O2 LEVELS
The Amplex Red Reagent (Molecular Probes) was used to detect
H2O2 levels in fresh lung tissue samples obtained from mice
treated with LPS in the presence or absence of GSH-EE supple-
mentation. Brieﬂy, an equal amount (∼10mg/sample) of lung
tissuewas incubated at 37˚C for 30min inmastermix solution con-
taining Amplex Red reagent, horseradish peroxidase, and a buffer
solution. Supernatant was then collected, ﬂuorescence was read
at excitation/emission 530/590 nm, and concentrations of H2O2
were determined through extrapolation from a standard curve.
Protein in the tissue samples was estimated by BCA assay and used
to normalize the detected H2O2 levels.
MEASUREMENT OF PROTEIN NITRATION
The total nitrated protein levels were measured in the lung
homogenates of mice treated with LPS in the presence or absence
of GSH-EE via a dot blot procedure. Brieﬂy, 30μg protein
was applied to a nitrocellulose membrane pre-soaked with Tris-
buffered saline (TBS). After the protein samples were completely
transferred, themembrane was blocked in 5% fat-freemilk for 1 h,
washed with TBS, and incubated with mouse anti-3-nitrotyrosine
(1:100, Calbiochem) antibody overnight. Finally, the membrane
was incubated with goat anti-mouse IgG for 2 h. The reactive dots
were visualized using chemiluminescence (Pierce Laboratories) on
a Kodak 440CF image station (New Haven, CT, USA). The band
intensity was quantiﬁed using Kodak 1D image processing soft-
ware. The protein expression was normalized by re-probing with
mouse anti β-actin antibody.
WESTERN BLOT ANALYSES
The lung tissue sample homogenates containing 25–50μg pro-
teins were separated on 4–20% denaturing polyacrylamide gels
and transferred to Immunoblot-PVDF membranes (Bio-Rad Lab,
Hercules, CA, USA). The membranes were blocked with 5%
non-fat dry milk in TBS containing 0.1% Tween (TBST). After
blocking, each membrane was incubated overnight at 4˚C with
either SOD1 (1:500, custom-made), SOD2 (1:1000, LS Biochem-
icals), Bax (1:1000, Cell Signaling, Danvers, MA, USA), cleaved
caspase 3 (1:1000, Cell Signaling, Danvers, MA, USA), cleaved
caspase 7 (1:1000, Cell Signaling, Danvers, MA, USA), Voltage-
dependent anion channels (VDAC; 1:500, Cell Signaling, Danvers,
MA, USA), or mouse β-actin (1:5000, Sigma), washed with TBST,
and then incubated with a IgG-horseradish peroxidase. The reac-
tive bands were visualized using chemiluminescence (SuperSignal
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West Femto substrate kit; Pierce) on a Kodak 440CF image sta-
tion. The band intensity was quantiﬁed using Kodak 1D image
processing software. To normalize for equal protein loading, the
blots were re-probed with either β-actin or VDAC.
DETERMINATION OF LACTATE AND PYRUVATE LEVELS
The lung tissues were homogenized in ice-cold 0.5M perchlo-
ric acid and centrifuged at 14,000 rpm for 20min. The collected
supernatants were then neutralized with 3M KHCO3 and used
for the lactate and pyruvate assays. The relative changes in lac-
tate levels were measured using a lactate assay kit (BioVision).
Thepyruvate levelswere determinedusing the spectrophotometric
enzymatic measurement assay at 340 nm, as previously published
(Sharma et al., 2008). NADH was used as a cofactor and lactate
dehydrogenase as the coenzyme.
ATP DETERMINATION
The ATP levels were quantiﬁed with a commercially available kit
(Invitrogen) based on the ﬁreﬂy luciferin-luciferase reaction. In
this reaction, ATP is consumed and light is emitted when ﬁreﬂy
luciferase catalyzes the oxidation of luciferin. The amount of light
emitted during the reaction is proportional to the availability of
ATP. The luminescence was determined using a FluoroscanAscent
plate luminometer (Thermo Electron, Corp.), and the ATP levels
reported in nanomoles per milligram protein.
MEASUREMENT OF CASPASE 3/7 ACTIVITY
Caspase 3/7 activity was detected with the caspase-Glo 3/7 assay
kit (Promega Corporation, Australia). Brieﬂy, 100μL caspase 3/7
reagents were added to each well with 50μL peripheral lung
homogenates containing equal amount of protein and incubated
for 1 h on rotary shaker at room temperature. The lumines-
cence intensity was measured using aMultiskanMicroplate reader
according to the manufacturer’s instructions.
DETERMINATION OF LUNG APOPTOSIS
The lung tissues were washed in PBS, ﬁxed in 4% paraformalde-
hyde (RT, 1 h), then placed in 30% sucrose (RT, 1 h), embedded
in O.C.T embedding medium (Tissue-Tek, Sakura Finetechnical,
Tokyo, Japan), and stored at −80˚C overnight. The embedded
tissue blocks were sectioned to 5μm slices and were analyzed
for the presence of apoptotic nuclei using the DeadEnd Fluoro-
metric TUNEL System (Promega, Madison, WI, USA). The DNA
breaks were labeled with ﬂuorescein-12-dUTP (green), and the
nuclei were stained with propidium iodide (red). The vascular
endothelial cell nuclei were labeled with anti-VonWillebrand Fac-
tor (1:500; Abcam, Cambridge, MA, USA), and Alexa Fluor 350
(blue) was used as the secondary antibody (Invitrogen, Carls-
bad, CA, USA). The sections were examined under a ﬂuorescence
microscope (Olympus, Japan).All imageswere captured by Image-
Pro Plus ver 5.0 (Media Cybernetics, Silver Spring, MD, USA).
The quantiﬁcation of the TUNEL positive endothelia nuclei and
total endothelia nuclei was processed by Image-Pro software and
presented as a percentage.
STATISTICAL ANALYSIS
The experimental results are expressed as mean± standard error
of the mean (SEM) for n = 5–6 for each group. The statistical
analysis was done usingGraphPadPrismversion 4.01 forWindows
(GraphPad Software, San Diego, CA,USA) using one-way analysis
of variance (ANOVA) and a Newman–Keuls multiple comparison
post hoc test. A value of P < 0.05 was considered signiﬁcant.
RESULTS
GSH-EE SUPPLEMENTATION ATTENUATES LPS-INDUCED OXIDATIVE
AND NITROSATIVE STRESS IN THE MOUSE LUNGS
To determine the effect of LPS exposure on oxidant and antiox-
idant homeostasis, we ﬁrst measured the glutathione levels in
the peripheral lung tissue of mice treated with or without LPS.
There was a signiﬁcant (approximately threefold) reduction in
GSH levels in LPS-treatedmouse lung when compared to controls
(Figure 1A) that was preserved with GSH-EE supplementation.
Earlier studies have provided evidence indicating that ROS and
RNS, particularly H2O2 and ONOO−, contributes to the patho-
genesis of ALI (Lang et al., 2002; Tasaka et al., 2008). Therefore,
we determined whether GSH-EE pre-treatment attenuated LPS-
induced oxidative and nitrosative stress in the mouse lung mice.
We found elevated H2O2 levels (Figure 1B) and increased pro-
tein nitration (Figure 1C). GSH-EE pre-treatment preserved the
LPS-induced H2O2, and nitrated protein levels in the mouse lung
(Figure 1).
GSH-EE SUPPLEMENTATION PRESERVES MITOCHONDRIAL FUNCTION
The loss of mitochondrial function upon exposure to LPS has been
implicated in the development of ALI (Kuwabara and Imajoh-
Ohmi, 2004). Superoxide dismutase-1 and 2 (SOD1 and SOD2)
are the two important antioxidant enzymes actively involved in
quenching harmful superoxide radicals. The lungs of LPS-treated
mice had a approximately twofold decrease in SOD1 and SOD2
protein levels (Figures 2A,B), while pre-treatment with GSH-EE
preserved both SOD1 and SOD2 protein levels. Under physiologi-
cal conditions where mitochondrial function is optimal, pyruvate
levels are higher than lactate, and thus any increase in lactate levels
will decrease the pyruvate-to-lactate ratio and can be extrapolated
to suggest a switch in mitochondrial ATP generation from glu-
coneogenesis to glycolysis (Shinde et al., 2005). The LPS-exposed
mice had a signiﬁcantly higher lactate/pyruvate ratio, thus indi-
cating a disruption in lung mitochondrial ATP generation from
gluconeogenesis (Figure 2C) and this was conﬁrmed by an overall
decrease in ATP levels in the LPS-treated mouse lung (Figure 2D).
Pre-treatment with GSH-EE blocked the increase in the lac-
tate/pyruvate ratio (Figure 2C) and preserved ATP generation
(Figure 2D).
GSH-EE SUPPLEMENTATION PREVENTS THE LPS-INDUCED
MITOCHONDRIAL TRANSLOCATION OF Bax AND CASPASE 3/7
ACTIVATION
Bax, amember of the Bcl-2 family of proteins, promotes apoptosis.
The translocation of Bax from the cytoplasm to the outer mito-
chondrial membrane stimulates apoptosis (Sarkar et al., 2003).We
found higher Bax protein levels in the mitochondria isolated from
the LPS-treated mice compared to the control mice (Figure 3A).
GSH-EE prevented the LPS-induced mitochondrial translocation
of Bax (Figure 3A). Activated caspases 3 and 7 are the execu-
tors of apoptotic cell death. Western blot analysis demonstrated a
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FIGURE 1 | GSH-EE supplementation improves LPS-mediated decrease in
GSH levels and attenuates LPS-induced oxidative and nitrosative stress.
Lungs from vehicle, LPS, GSH-EE+LPS, and GSH-EE treated mice were used
for the analysis of GSH, H2O2, and nitrated proteins levels. LPS signiﬁcantly
decreased GSH levels but GSH-EE pre-treatment prevented the loss of GSH
in these animals (A). The Amplex Red assay measurement indicated a twofold
increase in H2O2 levels in LPS-treated mice lungs as compared to controls
(B). Total nitrated protein levels were measured by dot blot analysis (C). LPS
caused signiﬁcant increases in the formation of H2O2 and nitrated proteins,
whereas GSH-EE pre-treatment prevented the LPS-induced increase in these
oxidative and nitrosative stress parameters. Values are mean±SEM;
n=6/group. *P <0.05 vs. vehicle; †P <0.05 vs. LPS alone.
twofold increase in activated caspase 3 (Figure 3B), and a three-
fold increase in activated caspase 7 (Figure 3C), protein levels after
LPS exposure. However, pre-treatment with GSH-EE signiﬁcantly
reduced only activated caspase 3, and not activated caspase 7, levels
(Figures 3B,C). Furthermore, using a luminescent assay, we found
a ﬁvefold increase in caspase 3/7 activity in LPS-treated mice, as
compared to the controls (Figure 3D). GSH-EE pre-treatment
partially decreased caspase 3/7 activity (Figure 3D). These results
suggest that GSH-EE pre-treatment attenuated the LPS-mediated
increase in caspase 3/7 activity primarily by decreasing active
caspase 3 levels.
GSH-EE SUPPLEMENTATION PROTECTS AGAINST LPS-INDUCED
APOPTOSIS
TUNEL staining was carried out to determine the effect
of GSH-EE pre-treatment on apoptosis in the LPS-exposed
mouse lungs. Sections were co-stained with TUNEL, a nuclei
marker (propidium iodide), and endothelial cell marker (VWF;
Figure 4A). The quantitation of TUNEL positive cells indicated
increased endothelial cell apoptosis in LPS-treated mice lungs,
which was attenuated with GSH-EE administration (Figure 4B).
In animals receiving vehicle or GSH-EE alone, no apoptotic nuclei
were observed (Figure 4).
DISCUSSION
The data presented in this study demonstrate thatGSH-EE supple-
mentation can protect the mouse lung against LPS-induced mito-
chondrial dysfunction and subsequent endothelial cell apoptosis.
The prior administration of GSH-EE: preserved LPS-mediated
attenuation of GSH levels; reduced the LPS-induced oxidative
and nitrosative stress; mitigated the LPS-mediated disruption of
mitochondrial ATP generation; prevented the LPS-induced loss of
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FIGURE 2 | GSH-EE supplementation prevents LPS-mediated
mitochondrial dysfunction. Protein extracts prepared from peripheral lungs
of vehicle, LPS, GSH-EE+LPS, and GSH-EE treated mice were analyzed by
Western blot analysis using a speciﬁc antiserum raised against SOD1 (A) or
SOD2 (B). Protein levels were normalized for loading using β-actin. A
representative blot and normalized densitometric values are shown. There
was a signiﬁcant decrease in SOD1 and SOD2 protein levels in LPS-treated
mice and this was prevented by GHS-EE pre-treatment. The lactate/pyruvate
ratio was also determined in all four groups (C). LPS-exposed mice had a
signiﬁcantly higher lactate/pyruvate ratio (C). Pre-treatment with GSH-EE
preserved the lactate/pyruvate ratio. There was a signiﬁcant reduction in lung
ATP levels after LPS exposure (D). However, the LPS-mediated decrease in
ATP levels was not observed in mice pre-treated with GSH-EE (D). Values are
mean±SEM; n=6/group. *P <0.05 vs. vehicle; †P <0.05 vs. LPS.
the mitochondrial antioxidant enzyme SOD2; decreased the LPS-
mediatedmitochondrial translocation of Bax, caspase 3 activation;
and prevented endothelial apoptosis.
GSH has been shown to protect cells against toxins, ROS,
and RNS (Messana et al., 1988). The depletion of GSH is an
important pathological event in the development of many neu-
rological, hepatic, and pulmonary diseases (Lee et al., 2004; Var-
gas et al., 2011). Although the cause of GSH depletion is not
clear, traditionally, it is thought that the decrease in GSH lev-
els is a direct consequence of increased production of ROS and
RNS. For example, a common pathological hallmark in var-
ious neurodegenerative disorders, such as amyotrophic lateral
sclerosis, Alzheimer’s, and Parkinson’s diseases, is the increase
in oxidative stress and a subsequent decrease in the GSH con-
tent. The intraperitoneal administration of the GSH precursor,
N -acetylcysteine (NAC), to rats has been shown to replen-
ish GSH levels and provide protection against oxidative dam-
age to brain proteins in these neurodegenerative disorders
(Pocernich et al., 2001). In addition, drugs, infections, and
inﬂammation in the liver increase the generation of ROS
and RNS with concomitant decreases in GSH levels. Liver
injury induced by acetaminophen also involves the severe
depletion of both cytosolic and mitochondrial GSH pools,
increased ROS generation, and cell death. NAC has been
proven to be effective in treating acetaminophen and non-
acetaminophen induced liver injury that, conversely, is poten-
tiated by GSH depletors (Jaeschke and Bajt, 2006; Lee et al.,
2009). In human studies, high-dose of NAC signiﬁcantly improved
the antioxidant proﬁle of the lungs by elevating GSH lev-
els and elicited an antioxidant effect at the alveolar surface
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FIGURE 3 | GSH supplementation prevents the LPS-mediated
translocation of Bax and caspase 3 activation. Bax protein levels were
measured in the mitochondria isolated from lung homogenates of vehicle,
LPS, LPS+GSH-EE, and GSH-EE treated mice usingWestern blot analysis
(A). Mitochondrial Bax protein levels from LPS-treated mouse lungs were
signiﬁcantly higher and GSH-EE prevented this translocation (A). Activated
caspase 3 and 7 protein levels and activity were also determined in lung
homogenates from all four groups. LPS-treated mice had signiﬁcantly
increased activated caspase 3 protein levels that was reduced by GSH-EE
pre-treatment (B). The activated caspase 7 protein levels were also
upregulated in LPS-treated mice, but did not change after GSH-EE
pre-treatment (C). The increase in activated caspase 3 protein levels
correlated with an increase in caspase 3/7 activity in lungs of mice
exposed to LPS, which was signiﬁcantly decreased in presence of GSH-EE
(D). Values are mean±SEM; n=3–6/group. *P <0.05 vs. vehicle;
†P <0.05 vs. LPS.
in patients with ﬁbrosing alveolitis. These biochemical changes
were accompanied by an improvement in the pulmonary func-
tion tests of these patients (Behr et al., 1997). In placebo-
controlled trials, orally administered NAC (≥600mg/day) has
been shown to signiﬁcantly improve the response to steroids,
increase the general well-being, and decrease exacerbation rates,
emergency room visits, days of illness, costs of hospitaliza-
tion, and work time loss in patients with chronic lung diseases
(Grandjean et al., 2000; Kasielski and Nowak, 2001; Poole and
Black, 2001).
In recent years, several studies have delineated the role of GSH
depletion and subsequent increase in oxidative stress and cytokine
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FIGURE 4 | GSH supplementation inhibits the LPS-induced endothelial
cell apoptosis in the mouse lung. Lung tissue sections from vehicle, LPS,
LPS+GSH-EE, and GSH-EE treated mice were analyzed for the presence
of apoptotic nuclei using the DeadEnd Fluorometric TUNEL System. The
DNA breaks were labeled with ﬂuorescein-12-dUTP (TUNEL; green), and
the nuclei were stained using propidium iodide (PI; red). Vascular
endothelial cells were labeled with anti-VonWillebrand Factor (VWF; blue)
(A). The quantiﬁcation of theTUNEL positive endothelial nuclei and total
endothelial nuclei was processed by Image-Pro software and presented as
a percentage. LPS treatment caused a signiﬁcant increase in endothelial
apoptosis and this was attenuated by GSH-EE pre-treatment (B). Values are
mean±SEM; n=4/group. *P <0.05 vs. vehicle; †P <0.05 vs. LPS.
production in the development of ALI. Although, the role of GSH
in the LPS-induced pulmonary inﬂammation may be cell speciﬁc.
For example, in murine macrophage-like cells (RAW 264.7), LPS
elevated GSH levels but when these LPS-treated cells were supple-
mented with GSH precursor, NAC, there was attenuation in the
LPS-dependent inﬂammation. However, the co-administration of
NAC with the anti-inﬂammatory agent, ethyl pyruvate, partially
reversed the anti-inﬂammatory effects of ethyl pyruvate suggest-
ing a dual role of GSH in these murine macrophage-like cells
(Song et al., 2004). In alveolar type II epithelial cells of rat lungs,
LPS decreased GSH, which resulted in an increase in TNF-α and
nuclear factor (NF)-kappa B levels (Zhang et al., 2008). Further-
more, the inhibition of GSH biosynthesis by buthionine sulfox-
imine (BSO) increased intracellular oxidative stress and enhanced
the production of IL-1β, IL-6, and TNF-α in the alveolar epithe-
lium (Haddad et al., 2001). In polymicrobial sepsis induced by
cecal ligation and puncture, exogenous GSH protected mice from
the lethal quantities of ROS and RNS produced by neutrophils. In
these mice, GSH stimulated the migration of neutrophils to the
site of infection but prevented their inﬁltration to distant sites,
thereby promoting the bactericidal, while limiting the cytolytic,
properties of neutrophils (Villa et al., 2002). Interestingly, tempol,
a membrane permeable free radical scavenger, ameliorated LPS-
induced GSH depletion in a mouse model of ALI (El-Sayed et al.,
2011), suggesting that oxidants potentiate the cellular reduction of
GSH levels. In support of these studies, our present data demon-
strated that LPS exposure signiﬁcantly diminished GSH levels in
the mouse lung, which correlated with an increase in pulmonary
oxidative and nitrosative stress. Exogenous supplementation with
GSH-EE in the presence of LPS restored the GSH levels and subse-
quently attenuated the LPS-induced elevation of both H2O2 and
total protein nitration in the mouse lung. We also found that
LPS-challenge led to the attenuation of SOD1 and SOD2 pro-
tein levels, whereas this decrease was not observed in GSH-EE
pre-treated mice. Although it is unclear how LPS treatment led to
the down-regulation of these enzymes in the mouse lung, based
upon previous studies, we can speculate that the activation of pro-
tein kinase B (PKB)/Akt by LPS and also by H2O2 leads to the
down-regulation of SOD levels (Wang et al., 2000; Monick et al.,
2001). Akt has been shown to phosphorylate and repress the DNA
binding activity of the transcription factor, FOXO3a (Forkhead
box class O), and consequently decrease the gene expression of
SOD2 (Li et al., 2006).
Intracellular redox status regulates various aspects of cellu-
lar function. Mitochondrial function is particularly susceptible to
oxidative damage. For example, unopposed oxidative stress selec-
tively inhibits mitochondrial respiratory-chain enzymes, thereby
decreasing ATP synthesis (Drahota et al., 2005). Studies in Parkin-
son’s and Alzheimer’s diseases have shown that if ONOO− is not
scavenged, e.g., by antioxidants, such as reduced GSH, it leads to
irreversible damage to critical cellular enzymes of the mitochon-
drial electron transport chain, alpha ketoglutarate dehydrogenase,
and pyruvate dehydrogenase (Foxton et al., 2007). Biochemically,
LPS increases the NADH:NAD ratio, thereby shifting the equi-
librium of the lactate dehydrogenase reaction toward lactate and
causing profound lactic acidosis. The resultant increase in the lac-
tate/pyruvate ratio is characteristic of attenuated oxidative phos-
phorylation in the mitochondria. Interestingly, our data demon-
strate thatmice supplementedwithGSH-EE prior to LPS exposure
are protected against the LPS-dependent increase in the lac-
tate/pyruvate ratio and maintain normal ATP levels. These results
compliment other studies that have shown that GSH protects the
mitochondria against oxidative insult under various pathologic
conditions such as reperfusion injury in the liver, ethanol-induced
toxicity, and diabetes (Sommer et al., 2012).
Mitochondrial regulation of apoptosis is central to cell survival.
A recent study demonstrated that LPS-mediated cellular apop-
tosis is dependent upon mitochondrial dysfunction in human
monoblastic U937 cells (Kuwabara and Imajoh-Ohmi, 2004).
Mitochondria regulate apoptosis by maintaining a delicate bal-
ance between pro- and anti-apoptotic Bcl-2 proteins. The pro-
apoptotic member of the Bcl-2 protein family, Bax, is normally
found in the cytosol where it acts as a sensor for cellular stress.
LPS-induced oxidative and nitrosative stress activates Bax, which
www.frontiersin.org May 2012 | Volume 3 | Article 161 | 7
Aggarwal et al. Glutathione supplementation and acute lung injury
then translocates to the outer mitochondrial membrane where it
interacts with anti-apoptotic proteins (Mishra and Dhali, 2007).
This interaction between Bax and anti-apoptotic proteins disrupts
their normal function,which leads to the formation of pores in the
mitochondria, allowing the exit of cytochrome c. In addition, ROS
independently oxidize mitochondrial pores further contributing
to cytochrome c release upon GSH depletion (Costantini et al.,
1996). Cytochrome c released from themitochondria activates the
caspase cascade,which then induces apoptosis. Recent studies have
shown that LPS triggers the release of cytochrome c from themito-
chondria to the cytoplasm, thereby activating the caspase cascade
and DNA fragmentation (Chuang et al., 2011). The pre-treatment
of human alveolar epithelial A549 cells with NAC signiﬁcantly
decreasedLPS-mediated caspase activation andDNAdamage, sug-
gesting an important role of GSH in ameliorating LPS-induced
cell death (Chuang et al., 2011). The loss of GSH and subsequent
decrease in ATP and ensuing cell death by dopamine metabolites
is prevented by GSH-EE and NAC supplementation, suggesting
a critical role of GSH in maintaining functional mitochondria in
Parkinson’s disease (Nunes et al., 2011). GSH also exhibited anti-
apoptotic effects in selenium induced apoptosis in HSC-3 human
oral squamous cell carcinoma cells and arsenic trioxide-induced
apoptosis in lymphoma cells (Takahashi et al., 2005). Thus, our
ﬁndings in the mouse model of ALI concur with these studies and
demonstrate that GSH-EE pre-treatment prevents LPS-induced
pulmonary endothelial cell apoptosis.
In conclusion, the results presented in this study suggest that
the modulation of the cellular redox equilibrium by GSH pre-
serves oxidative phosphorylation in the mitochondria in response
to LPS-induced oxidative damage and subsequent cellular apopto-
sis. Although clinical trials involving the use of antioxidants have
not shown promising results in chronically ill patients, the acute
burst of oxidative, and nitrosative stress seen in ALI may be more
susceptible to antioxidant therapy. Based upon past studies and
our present data, we conclude that GSH depletion plays a vital role
in the pathogenesis of ALI, and therefore, GSH supplementation
may act as an important adjuvant therapy to reverse the disease
process.
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